Tag: #Global Trends

Sanofi has entered into a definitive multi-year licensing agreement with Owkin, an agentic AI company pioneering biological artificial superintelligence for... Read more

A Los Angeles jury has ruled in favor of Johnson & Johnson (J&J) in a product liability lawsuit initiated by... Read more

U.S. biotechnology company Incyte Pharma is nearing a definitive agreement valued at up to $2 billion to acquire Star Therapeutics,... Read more

Drugmaker Eli Lilly has presented milestone clinical trial results to medical professionals, demonstrating that its next-generation obesity drug, retatrutide, significantly... Read more

Pharmaceutical giant Pfizer has presented novel clinical trial data demonstrating that a monthly dose of its experimental obesity drug exhibits... Read more

Johnson & Johnson (J&J) has reported that its investigational monoclonal antibody, nipocalimab, successfully met its primary clinical endpoint in the... Read more

Bayer has officially announced that new investigational datasets from its Phase III KERENDIA® (finerenone) clinical development program will be showcased... Read more

Alkem Laboratories has officially announced the commercial launch of semaglutide delivered via single-shot pre-filled syringes. With this deployment, Alkem cements... Read more

Singapore’s Health Sciences Authority (HSA) has officially approved MSD’s Enflonsia (clesrovimab). The therapeutic asset is indicated for the prevention of... Read more